Retina/Vitreous News

Wellness company HealthyCell has announced the launch of Eye Health, the newest supplement in the company’s MicroGel product line, which is designed to promote visual acuity, protect against oxidative stress and support retinal health.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Sean D. Adrean, MD, discusses data on aflibercept 8 mg vs. aflibercept 2 mg for the treatment of diabetic macular edema at 1 year.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Paulo E. Stanga, MD, explains how the Bionic Eye System provides artificial vision for patients with vision loss due to inherited retinal diseases.

The FDA approved Yesafili and Opuviz as the first interchangeable biosimilars to Eylea, according to a press release from the FDA.

Ophthalmologists can attend interactive sessions, network with colleagues and earn CME credits at this year’s Kiawah Eye, organized by Healio Live.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher S. Dhoot, MD, discusses 52-week phase 1 data for Axpaxli for the treatment of neovascular age-related macular degeneration.

Intravitreal pegcetacoplan was associated with delayed atrophy of retinal pigment epithelium and photoreceptors among patients with geographic atrophy secondary to age-related macular degeneration, according to research.

SEATTLE — In this Healio Video Perspective from the Retina World Congress, Andrew A. Moshfeghi, MD, MBA, discusses treating patients with age-related macular degeneration with concomitant geographic atrophy and choroidal neovascularization.

The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Ashkan M. Abbey, MD, shares topline data from the phase 2 DAVIO 2 trial investigating Duravyu for wet age-related macular degeneration.